
|
|
|
| For 100 years, C. R. Bard, Inc. has committed its resources to creating innovative products and services that meet the needs of healthcare providers and patients. Today, BARD is a worldwide leader in products that focus on Disease State Management in three key areas: Vascular, Urology and Oncology. To complement these areas, BARD has a complete line of advanced Surgical Specialty Products and Services. |
|
Please note that the information in each of the above press releases is only current as of the date of the release. C. R. Bard, Inc. undertakes no obligation to update the information in the press releases to reflect new information, the occurrence of future events or circumstances, or otherwise. |
|
|
BARDEX® I.C. System with Anti-Infective Foley Catheter utilizing Bard® hydrogel and Bacti-Guard®* silver alloy coating
There are in excess of 2 million nosocomial (hospital-acquired) infections every year in the United States.1 Catheter-associated urinary tract infections (CAUTIs) comprise approximately 40% of all nosocomial infections.
|